Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Seidl

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical Neurology and Neurosurgery|March 10, 2012
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohortT Kalincik, D Horakova, O Dolezal, et al.
European Neurology|June 9, 2012
Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year studyM Vaneckova, T Kalincik, J Krasensky, et al.
Casopis Lekaru Ceskych|May 22, 2003
[Multiple sclerosis and magnetic resonance]M Jinochová, Z Seidl, J Obenberger, et al.
Sbornik Lekarsky|February 28, 2001
[EEG findings in patients with systemic lupus erythematosus]V Peterová, J Faber, C Dostál, et al.
Sbornik Lekarsky|April 12, 2003
Adipose tissue distribution in obese females. Relationship to androgens, cortisol, growth hormone and leptinM Kunesová, V Hainer, J Obenberger, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosusL Podrazilová, V Peterová, M Olejárová, et al.
Vnitrni Lekarstvi|October 6, 2007
[Randomly discovered enlargement in the region of sella turcica]V Hána, Z Seidl, M Vanĕcková, et al.
Acta Neurologica Scandinavica|December 22, 2005
Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysisD Horínek, P Petrovický, J Hort, et al.
AJNR. American Journal of Neuroradiology|April 29, 2017
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple SclerosisA Burgetova, P Dusek, M Vaneckova, et al.
European Journal of Neurology|April 24, 2015
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1aT Uher, D Horakova, T Kalincik, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Neurology and Neurosurgery|March 10, 2012
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohortT Kalincik, D Horakova, O Dolezal, et al.
European Neurology|June 9, 2012
Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year studyM Vaneckova, T Kalincik, J Krasensky, et al.
Casopis Lekaru Ceskych|May 22, 2003
[Multiple sclerosis and magnetic resonance]M Jinochová, Z Seidl, J Obenberger, et al.
Sbornik Lekarsky|February 28, 2001
[EEG findings in patients with systemic lupus erythematosus]V Peterová, J Faber, C Dostál, et al.
Sbornik Lekarsky|April 12, 2003
Adipose tissue distribution in obese females. Relationship to androgens, cortisol, growth hormone and leptinM Kunesová, V Hainer, J Obenberger, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosusL Podrazilová, V Peterová, M Olejárová, et al.
Vnitrni Lekarstvi|October 6, 2007
[Randomly discovered enlargement in the region of sella turcica]V Hána, Z Seidl, M Vanĕcková, et al.
Acta Neurologica Scandinavica|December 22, 2005
Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysisD Horínek, P Petrovický, J Hort, et al.
AJNR. American Journal of Neuroradiology|April 29, 2017
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple SclerosisA Burgetova, P Dusek, M Vaneckova, et al.
European Journal of Neurology|April 24, 2015
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1aT Uher, D Horakova, T Kalincik, et al.
Pageof 5